SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-040429
Filing Date
2019-07-02
Accepted
2019-07-02 17:11:01
Documents
2
Period of Report
2019-06-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1485
2 EX-24 DOCUMENT attachment1.htm EX-24 4249
  Complete submission text file 0001209191-19-040429.txt   7102
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Issuer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 3545 JOHN HOPKINS COURT SUITE 250 SAN DIEGO CA 92121
Business Address
Lucas Svetlana (Reporting) CIK: 0001781292 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37378 | Film No.: 19938758